Bookmarks
ID-249-4: Extension: The impact of COVID-19 on antibiotic prescribing in North West London
Safe People
Organisation name
Imperial College London
Applicant name(s)
Paul Aylin
Funders/ Sponsors
Safe Projects
Project ID
ID-249-4
Lay summary
understanding the impact of the COVID-19 pandemic and national response
Public benefit statement
Tackling AMRis one of the nation’s highest public health priorities. Our work is in line with UK’s 20 year vision of AMR, and England’s national strategy for infectious diseases. Benefited from the unique setting of our research group (NIHR HPRU in HCAI and AMR), which is a close collaboration between Imperial College, UKHSA, and local NHS trusts, research outputs can be disseminated and translated to policy and patient management guidelines rapidly to enhance the quality of care. In addition, the highly granular patient level data in iCARE environment provides knowledge complementary to the data produced by UKHSA at national level (covered larger population but less detailed). This work will help identify any sub-optimal prescribing practices in primary and secondary care, any newly emerged drug resistant infections, and any unintended conseuqnces associated with national prescribing guidelines and prescribing interventions.
Other approval committees
Project start date
18/08/2022
Project end date
20/02/2026
Latest approval date
20/08/2025
Safe Data
Dataset(s) name
Data sensitivity level
De-Personalised
Release/Access date
22/09/2025
Safe Setting
Access type
TRE